Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,568.40
(
0.05%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
101.81
(
0.27%
)
Bitcoin
77,820.01
(
-1.06%
)
News Focus
News Focus
Post# of 822995
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

dr_lowenstein

Send PM Follow Ignore
Followers 83
Posts 36201
Boards Moderated 0
Alias Born 03/09/2010

dr_lowenstein

Re: Doc logic post# 501574

Friday, 08/05/2022 12:31:56 PM

Friday, August 05, 2022 12:31:56 PM

Post# of 822995
Primary Outcome Measures:
1. The primary objective of this study is to compare progression-free-survival (PFS) between patients treated with DCVax-Brain and concurrent control patients
Secondary Outcome Measures:
1. The secondary objective is to compare overall survival, measured as time-to-death, between DCVax-Brain treated vs. concurrent control patients.

THEY HATE ME CAUSE THEY AINT ME

NAILED IT ON EVERY STOCK

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News